Stockreport

Roche to Halt Lung Cancer Drug Study in Fresh Setback [BNN Bloomberg (Canada)]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF The medicine, called tiragolumab, was combined with another Roche treatment and chemotherapy in the clinical trial. The trio appeared less effective than Merck & Co.'s [Read more]